Literature DB >> 25637053

Regulation of cell surface transferrin receptor-2 by iron-dependent cleavage and release of a soluble form.

Alessia Pagani1, Maud Vieillevoye2, Antonella Nai1, Marco Rausa1, Meriem Ladli2, Catherine Lacombe2, Patrick Mayeux2, Frédérique Verdier3, Clara Camaschella1, Laura Silvestri4.   

Abstract

Transferrin receptor-2 is a transmembrane protein whose expression is restricted to hepatocytes and erythroid cells. Transferrin receptor-2 has a regulatory function in iron homeostasis, since its inactivation causes systemic iron overload. Hepatic transferrin receptor-2 participates in iron sensing and is involved in hepcidin activation, although the mechanism remains unclear. Erythroid transferrin receptor-2 associates with and stabilizes erythropoietin receptors on the erythroblast surface and is essential to control erythrocyte production in iron deficiency. We identified a soluble form of transferrin receptor-2 in the media of transfected cells and showed that cultured human erythroid cells release an endogenous soluble form. Soluble transferrin receptor-2 originates from a cleavage of the cell surface protein, which is inhibited by diferric transferrin in a dose-dependent manner. Accordingly, the shedding of the transferrin receptor-2 variant G679A, mutated in the Arginine-Glycine-Aspartic acid motif and unable to bind diferric transferrin, is not modulated by the ligand. This observation links the process of transferrin receptor-2 removal from the plasma membrane to iron homeostasis. Soluble transferrin receptor-2 does not affect the binding of erythropoietin to erythropoietin receptor or the consequent signaling and partially inhibits hepcidin promoter activation only in vitro. Whether it is a component of the signals released by erythropoiesis in iron deficiency remains to be investigated. Our results indicate that membrane transferrin receptor-2, a sensor of circulating iron, is released from the cell membrane in iron deficiency. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25637053      PMCID: PMC4380718          DOI: 10.3324/haematol.2014.118521

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  33 in total

1.  Serum transferrin receptor is a truncated form of tissue receptor.

Authors:  Y J Shih; R D Baynes; B G Hudson; C H Flowers; B S Skikne; J D Cook
Journal:  J Biol Chem       Date:  1990-11-05       Impact factor: 5.157

Review 2.  The trans-Golgi network: a late secretory sorting station.

Authors:  L M Traub; S Kornfeld
Journal:  Curr Opin Cell Biol       Date:  1997-08       Impact factor: 8.382

3.  Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis.

Authors:  R E Fleming; M C Migas; C C Holden; A Waheed; R S Britton; S Tomatsu; B R Bacon; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

4.  Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo.

Authors:  H Kawabata; R S Germain; P T Vuong; T Nakamaki; J W Said; H P Koeffler
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

Review 5.  Soluble transferrin receptor for the evaluation of erythropoiesis and iron status.

Authors:  Yves Beguin
Journal:  Clin Chim Acta       Date:  2003-03       Impact factor: 3.786

6.  Regulation of expression of murine transferrin receptor 2.

Authors:  H Kawabata; R S Germain; T Ikezoe; X Tong; E M Green; A F Gombart; H P Koeffler
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

7.  Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells.

Authors:  H Kawabata; T Nakamaki; P Ikonomi; R D Smith; R S Germain; H P Koeffler
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

8.  The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22.

Authors:  C Camaschella; A Roetto; A Calì; M De Gobbi; G Garozzo; M Carella; N Majorano; A Totaro; P Gasparini
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

9.  Redundant and distinct functions for dynamin-1 and dynamin-2 isoforms.

Authors:  Y Altschuler; S M Barbas; L J Terlecky; K Tang; S Hardy; K E Mostov; S L Schmid
Journal:  J Cell Biol       Date:  1998-12-28       Impact factor: 10.539

10.  The second transferrin receptor regulates red blood cell production in mice.

Authors:  Antonella Nai; Maria Rosa Lidonnici; Marco Rausa; Giacomo Mandelli; Alessia Pagani; Laura Silvestri; Giuliana Ferrari; Clara Camaschella
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

View more
  22 in total

Review 1.  Liver iron sensing and body iron homeostasis.

Authors:  Chia-Yu Wang; Jodie L Babitt
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

2.  Increasing serum transferrin to reduce tissue iron overload due to ineffective erythropoiesis.

Authors:  Emanuela Tolosano
Journal:  Haematologica       Date:  2015-05       Impact factor: 9.941

3.  Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway.

Authors:  Mastura Wahedi; Aaron M Wortham; Mark D Kleven; Ningning Zhao; Shall Jue; Caroline A Enns; An-Sheng Zhang
Journal:  J Biol Chem       Date:  2017-09-18       Impact factor: 5.157

4.  Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload.

Authors:  Aaron M Wortham; Devorah C Goldman; Juxing Chen; William H Fleming; An-Sheng Zhang; Caroline A Enns
Journal:  J Biol Chem       Date:  2020-02-13       Impact factor: 5.157

Review 5.  The mutual crosstalk between iron and erythropoiesis.

Authors:  Clara Camaschella; Alessia Pagani; Laura Silvestri; Antonella Nai
Journal:  Int J Hematol       Date:  2022-05-27       Impact factor: 2.319

6.  Comment on: PACE4 (PCSK6): another proprotein convertase linked to iron homeostasis?

Authors:  Alessia Pagani; Meriem Ladli; Antonella Nai; Frederique Verdier; Clara Camaschella; Laura Silvestri
Journal:  Haematologica       Date:  2015-09       Impact factor: 9.941

7.  PACE4 (PCSK6): another proprotein convertase link to iron homeostasis?

Authors:  Johann Guillemot; Nabil G Seidah
Journal:  Haematologica       Date:  2015-09       Impact factor: 9.941

8.  Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model.

Authors:  Irene Artuso; Maria Rosa Lidonnici; Sandro Altamura; Giacomo Mandelli; Mariateresa Pettinato; Martina U Muckenthaler; Laura Silvestri; Giuliana Ferrari; Clara Camaschella; Antonella Nai
Journal:  Blood       Date:  2018-09-12       Impact factor: 22.113

9.  Coordination of iron homeostasis by bone morphogenetic proteins: Current understanding and unanswered questions.

Authors:  Allison L Fisher; Jodie L Babitt
Journal:  Dev Dyn       Date:  2021-05-25       Impact factor: 3.780

Review 10.  Targeting iron metabolism in drug discovery and delivery.

Authors:  Bart J Crielaard; Twan Lammers; Stefano Rivella
Journal:  Nat Rev Drug Discov       Date:  2017-02-03       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.